earnings
Abbott Reports Second-Quarter 2026 Results and Raises Full-Year EPS Guidance
Abbott announced its second-quarter 2026 financial results, with sales growth of 13.0% and adjusted EPS of $1.31. The company reaffirmed its full-year sales growth guidance and raised its EPS outlook.
AS1 NewsSource: prnewswire.com
Abbott has reported its financial results for the second quarter of 2026. The company achieved a sales increase of 13.0%, with comparable sales growth of 4.8%. The GAAP diluted earnings per share (EPS) for the quarter was $0.53, while adjusted EPS was $1.31. These results reflect Abbott's ongoing performance in the healthcare sector.
In addition to the quarterly results, Abbott reaffirmed its full-year 2026 guidance for comparable sales growth, maintaining a range of 6.5% to 7.5%. The company also raised its full-year adjusted EPS outlook, indicating confidence in its financial trajectory.
This update is significant for investors and analysts monitoring Abbott's performance and the healthcare industry. The improved guidance and strong quarterly results suggest positive momentum for the company.
The impact on Abbott's stock and investor sentiment will depend on market reactions to these results and outlook updates. Overall, the report reinforces Abbott's position in the healthcare market and its growth prospects for 2026.
The results and guidance update are likely to positively influence investor sentiment and Abbott's stock performance.